MedTrace Logo

Endovascular Treatment of Thoracic Aortic Disease

NCT00583817 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2026-05-04

No results posted yet for this study

Summary

The purpose of this study is to assess the role endovascular therapy to treat aortic disease involving the ascending aorta, the aortic arch, and the visceral segment of the aorta (or thoracoabdominal aorta)

Conditions

  • Thoracic Aortic Aneurysms
  • Dissecting, Aneurysm
  • Ascending Aorta Aneurysm
  • Aortic Arch; Aneurysm, Dissecting
  • Ascending Aortic Dissection
  • Thoracoabdominal Aortic Aneurysm
  • Renal Artery Aneurysm
  • Superior Mesenteric Artery Aneurysm
  • Aortic Dissection

Interventions

DEVICE

Endovascular stent-graft implantation

Endovascular repair of aorta: Patient-specific F/BEVAR treatment

Sponsors & Collaborators

Principal Investigators

  • Matthew J Eagleton, MD · Massachusetts General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-25
Primary Completion
2030-12-31
Completion
2030-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00583817 on ClinicalTrials.gov